SynBioBeta Speaker
Stephanie Wisner
Co-founder & CBO
Centivax
May 2026, SynBioBeta
Speaker
Stephanie A. Wisner co-founded the biotech start-up, Centivax, where she is now Chief Business Officer. At Centivax, she has been instrumental in securing over $70M in private financing and $24M in non-dilutive funding from organizations such as the National Institutes of Health (NIH), Department of Defense (DoD), and the United States Navy. She has also advised multiple biotech start-ups on business and commercialization strategy through her consulting business, BioVenture Advising LLC and spent several years at ARCH Venture Partners. In 2022, she was named to the Forbes 30 Under 30 list for Healthcare. She completed her MBA at the University of Chicago Booth School of Business, with concentrations in finance, accounting, and entrepreneurship. She received her Bachelor’s Degree in chemistry and chemical biology from Cornell University and was awarded the Einhorn Discovery Research Grant for her independent research on cancer. Building Backwards to Biotech was an Amazon #1 New Release in the Category of Biotechnology. The book is currently taught as part of bioentrepreneurial programming at multiple top institutions, including Dartmouth College, Cornell University, and others. She is also an Entrepreneur-in-Residence and former Faculty at Cornell University. You can reach Stephanie at bioventureadvising.com.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
Join for the latest
SynBioBeta event updates.